The Role of the I/D Polymorphism of the ACE Gene in the Development of Atrial Fibrillation

Objective. To study associations of I/D polymorphism of the ACE gene with risk of atrial fibrillation (AF) with the aim of detecting groups of patients prone to development of this disease. Materials and methods. We examined 90 probands with confirmed diagnosis of AF and 144 their I, II, III degrees relatives. These families constituted a core group of our study. The control group comprised 100 relatively healthy people without history of cardiovascular diseases. Methods used in all patients included clinical examination, electrocardiography, echocardiography, Holter ECG monitoring, veloergometry, transesophageal left atrial pacing, molecular-genetic tests. Results. We found statistically significant predominance of genotype II homozygous carriers among probands with primary AF compared with the control group (30.0±7.2% and 14.0±3.5%, respectively; p=0.028). Homozygous carriers of DD genotype statistically significantly prevailed in the control group compared with group of probands with primary AF (36.0±4.8% and 15.0%±5.6%; p=0.014). Carriers of homozygous genotype II for common allele statistically significantly prevailed among probands with secondary AF compared with the control group (34.0±6.7% and 14.0±3.5%, respectively; p=0.004). Homozygous carriers of DD genotype for the rare allele statistically significantly prevailed among control subjects compared to probands with secondary AF (36.0±4.8% and 10.0%±4.2%, respectively; p=0.001). Conclusion. Thus, compared with controls statistically significant preponderance of carriers of homozygous genotype II for common allele was found among probands with both primary and secondary AF. At the same time compared with probands there was a statistically significant predominance of homozygous carriers of DD genotype for the rare allele in the control group. Our findings suggest the heterogeneous nature of AF and confirm that DD genotype homozygosity can be protective against the development of AF.

фибрилляция предсердий, I/D полиморфизм гена ACE, atrial fibrillation, I/D ACE gene polymorphism

1. Baruscotti M. Bucchi A., Difrancesco D. Physiology and pharmacology of the cardiac pacemaker (“funny") current. Pharmacol 'Rier 2005;107 (1):59-79. doi: 10.1016/j. pharmthera. 2005.01.005

2. Afifi A., Jejzen S. Statistical analysis. М.: Mir 1982;194 p. Russian (Афифи А., Эйзен С. Статистический анализ: пер. с нем. М.: Мир 1982;194 с.).

3. Shabalin V. N. Mathematical methods in the study of the genetics of multifactorial diseases. М.: 1994; 69 p. Russian (Шабалин В. Н. Математические методы в изучении генетики мультифактори-альных заболеваний. М.: 1994;69 с.).

4. Flejs Dzh. Statistical methods for the study of tables shares and proportions. Finansy i statistika 1989;319 p. Russian (Флейс Дж. Статистические методы для изучения таблиц долей и пропорций: пер. с англ. М.: Финансы и статистика 1989;319 с.).

5. Pollard D. Handbook of Computational Statistics Methods. Finansy i statistika 1982;344 p. Russian (Поллард Д. Справочник по вычислительным методам статистики: пер. с англ. М.: Финансы и статистика 1982;344 с.).

6. Online calculator frequency distribution of genotypes for the Hardy-Weinberghttp://www.oege.org/software/hwe-mr-calc. shtml.

7. Huang M., Gai X., Yang X. et al. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hyper tensive heart disease. Clin Chem Lab Med 2009;47 (1):32-37. DOI: 10.1515/CCLM. 2009.023.

8. Gensini F., Padeletti L., Fatini C. et al. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol 2003;26 (1):295-298. doi: 10.1046/j. 1460-9592.2003.00036.

9. Fatini C., Sticchi E., Gensini F. et al. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. Int J Cardiol 2007;120 (1):59-65. doi: 10.1016/j. ijcard. 2006.08.079.

10. Darbar D., Motsinger A. A., Ritchie M. D. et al. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 2007; 4(6):743-749. doi: 10.1016/j. hrthm. 2007.02.006.

11. Ma R., Li X., Su G. et al. Angiotensin-converting enzyme insertion/deletion gene polymorphisms associatedwith risk ofatrial fibrillation: Ameta-analysis of 23 case-control studies. J Renin-Angiotensin-Aldosterone System 2015;16 (4):793-800. doi: 10.1177/1470320315587179.

12. Xiao P., Ling Z., Woo K. et al. Renin-angiotensin system-related gene polymorphisms are associated with risk of atrial fibrillation. Am Heart J 2010;160 (3):496-505. doi: 10.1016/j. ahj. 2010.06.013.